Skip to main content
. 2022 Feb 3;1(2):141–146. doi: 10.1016/j.gastha.2021.11.007

Table 2.

Baseline Patient Characteristics

Variable N (%) or mean (SD)a
Age 58.4 (SD 19.1)
Male 34 (33%)
Female 69 (67%)
White 86 (84.3%)
Black 8 (7.8%)
Native American 1 (1%)
Other race/ unknown 5 (4.9%)
BMI 26.7 (SD 6.5)
Active smoker 16 (16.3%)
Inflammatory bowel disease history 20 (19.4%)
Irritable bowel disease history 11 (10.68%)
Medications before FMT
 Acid suppression 42 (40.8%)
 Immunosuppressive medications 24 (23.3%)
 Probiotics 39 (37.9%)

SD, standard deviation.

a

N = 103.